NCT00075491 2013-01-24
Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2 Terminated
National Cancer Institute (NCI)
SWOG Cancer Research Network